Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil

View ORCID ProfileFredi A. Diaz-Quijano, View ORCID ProfileJosé Mário Nunes da Silva, View ORCID ProfileFabiana Ganem, View ORCID ProfileSilvano Oliveira, View ORCID ProfileAndrea L. Vesga-Varela, View ORCID ProfileJulio Croda
doi: https://doi.org/10.1101/2020.04.05.20047944
Fredi A. Diaz-Quijano
1Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, SP, 01246- 904, Brazil
2Laboratório de Inferência Causal em Epidemiologia da Universidade de São Paulo (LINCE-USP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fredi A. Diaz-Quijano
  • For correspondence: frediazq@usp.br
José Mário Nunes da Silva
2Laboratório de Inferência Causal em Epidemiologia da Universidade de São Paulo (LINCE-USP)
3Postgraduate Student, Epidemiology, School of Public Health, University of São Paulo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Mário Nunes da Silva
Fabiana Ganem
4Secretariat of Health Surveillance, Department of Immunization and Communicable Diseases, Ministry of Health, Brasília, DF, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fabiana Ganem
Silvano Oliveira
4Secretariat of Health Surveillance, Department of Immunization and Communicable Diseases, Ministry of Health, Brasília, DF, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Silvano Oliveira
Andrea L. Vesga-Varela
2Laboratório de Inferência Causal em Epidemiologia da Universidade de São Paulo (LINCE-USP)
5Postgraduate Student, Public Health, School of Public Health, University of São Paulo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea L. Vesga-Varela
Julio Croda
4Secretariat of Health Surveillance, Department of Immunization and Communicable Diseases, Ministry of Health, Brasília, DF, Brazil
6School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil
7Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, United States of America
8Oswaldo Cruz Foundation, Mato Grosso do Sul, Campo Grande, MS, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julio Croda
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background COVID-19 diagnosis is a critical problem, mainly due to the lack or delay in the test results. We aimed to obtain a model to predict SARS-CoV-2 infection in suspected patients reported to the Brazilian surveillance system.

Methods We analyzed suspected patients reported to the National Surveillance System that corresponded to the following case definition: patients with respiratory symptoms and fever, who traveled to regions with local or community transmission or who had close contact with a suspected or confirmed case. Based on variables routinely collected, we obtained a multiple model using logistic regression. The area under the receiver operating characteristic curve (AUC) and accuracy indicators were used for validation.

Results We described 1468 COVID-19 cases (confirmed by RT-PCR) and 4271 patients with other illnesses. With a data subset, including 80% of patients from Sao Paulo (SP) and Rio Janeiro (RJ), we obtained a function which reached an AUC of 95.54% (95% CI: 94.41% - 96.67%) for the diagnosis of COVID-19 and accuracy of 90.1% (sensitivity 87.62% and specificity 92.02%). In a validation dataset including the other 20% of patients from SP and RJ, this model exhibited an AUC of 95.01% (92.51% – 97.5%) and accuracy of 89.47% (sensitivity 87.32% and specificity 91.36%).

Conclusion We obtained a model suitable for the clinical diagnosis of COVID-19 based on routinely collected surveillance data. Applications of this tool include early identification for specific treatment and isolation, rational use of laboratory tests, and input for modeling epidemiological trends.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work had no specific funding. FADQ and JC were granted a fellowship for research productivity from the Brazilian National Council for Scientific and Technological Development (CNPq), process/contract identification: 312656/2019-0 and 310551/2018-8, respectively.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • After peer review, we made several corrections and included clarifications about methods. We also added the calibration plots of the predictive model.

Data Availability

Data subject to third party restrictions.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted August 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil
Fredi A. Diaz-Quijano, José Mário Nunes da Silva, Fabiana Ganem, Silvano Oliveira, Andrea L. Vesga-Varela, Julio Croda
medRxiv 2020.04.05.20047944; doi: https://doi.org/10.1101/2020.04.05.20047944
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil
Fredi A. Diaz-Quijano, José Mário Nunes da Silva, Fabiana Ganem, Silvano Oliveira, Andrea L. Vesga-Varela, Julio Croda
medRxiv 2020.04.05.20047944; doi: https://doi.org/10.1101/2020.04.05.20047944

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)